![Serum HER-2](https://marketing.webassets.siemens-healthineers.com/b02147015e10e668/72badb1873eb/v/5f365da17ae0/siemens-healthineers_clinical_serum-HER.jpg)
serum HER-2/neu: Helping Women with Metastatic Breast Cancer
The serum HER-2/neu test is a simple blood test for over 150,000 women living with metastatic breast cancer.1 For the thousands of women diagnosed with metastatic breast cancer each year, the Siemens serum HER-2/neu test is the automated serum HER-2/neu test available for sale in the U.S. for monitoring their Serum HER-2/neu status during therapy. The serum HER-2/neu test is indicated for follow-up and monitoring patients with metastatic breast cancer and initial serum level >15 ng/mL.
serum HER-2/neu Status: Providing Critical Information for Metastatic Disease Assessment
Less than 15% increase is considered to indicate a lack of progression. Increase of equal or greater than 15% was considered to indicate progression.*
Monitoring serum HER-2/neu levels yields important information about response to therapy and cancer progression, and may help physicians make more informed decisions when developing and modifying patient treatment regimen. 2-4
Understanding the serum HER-2/neu test
How to use a blood-based HER-2/neu immunoassay for active surveillance during treatment.**